News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SurModics Inc. (SRDX) IVD Introduces A New BioFX® TMB Enhanced HRP Membrane Substrate



9/20/2011 10:44:35 AM

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics IVD introduces BioFX® TMB Enhanced HRP Membrane Substrate. SurModics IVD, a wholly owned subsidiary of SurModics, Inc. (Nasdaq: SRDX), is a market leader for immunoassay reagents for diagnostic test kits used to detect absence or presence of disease.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES